001442621 000__ 03802cam\a2200577\i\4500
001442621 001__ 1442621
001442621 003__ OCoLC
001442621 005__ 20230310003427.0
001442621 006__ m\\\\\o\\d\\\\\\\\
001442621 007__ cr\nn\nnnunnun
001442621 008__ 211027t20222022sz\a\\\\ob\\\\100\0\eng\d
001442621 019__ $$a1287765870$$a1291259285$$a1310415299
001442621 020__ $$a9783030831141$$q(electronic book)
001442621 020__ $$a3030831140$$q(electronic book)
001442621 020__ $$z9783030831134$$q(print)
001442621 0247_ $$a10.1007/978-3-030-83114-1$$2doi
001442621 035__ $$aSP(OCoLC)1282300638
001442621 040__ $$aFIE$$beng$$erda$$epn$$cFIE$$dGW5XE$$dYDX$$dDCT$$dOCLCF$$dOCLCO$$dUKAHL$$dLVT$$dGWL$$dOCLCQ$$dOCLCO$$dOCLCQ
001442621 049__ $$aISEA
001442621 050_4 $$aK1519.D78$$bA75 2022
001442621 08204 $$a346.04/86$$223
001442621 24500 $$aAccess to medicines and vaccines :$$bimplementing flexibilities under intellectual property law /$$cCarlos M. Correa, Reto M. Hilty, editors.
001442621 264_1 $$aCham, Switzerland :$$bSpringer,$$c[2022]
001442621 264_4 $$c©2022
001442621 300__ $$a1 online resource (x, 369 pages) :$$bcolor illustrations
001442621 336__ $$atext$$btxt$$2rdacontent
001442621 337__ $$acomputer$$bc$$2rdamedia
001442621 338__ $$aonline resource$$bcr$$2rdacarrier
001442621 347__ $$atext file
001442621 347__ $$bPDF
001442621 504__ $$aIncludes bibliographical references.
001442621 50500 $$tInterpreting the Flexibilities Under the TRIPS Agreement /$$rCarlos M. Correa --$$tIntellectual Property Exhaustion and Parallel Imports of Pharmaceuticals : a Comparative and Critical Review /$$rIrene Calboli --$$tCompulsory Licenses and Government Use : Challenges and Opportunities /$$rYousuf A. Vawda --$$tAccess to CRISPR Genome Editing Technologies : Patents, Human Rights and the Public Interest /$$rDuncan Matthews --$$tBolar Exception /$$rViviana Munoz Tellez --$$tPatent Oppositions in India /$$rSandeep Kanak Rathod --$$tProtection of Clinical Test Data and Public Health : A Proposal to End the Stronghold of Data Exclusivity /$$rEllen 't Hoen --$$tCourts and Pharmaceutical Patents : From Formalist Positivism to the Emergence of a Global Law /$$rCalixto Salomao Filho, Vitor Henrique Pinto Ido --$$tRobust Patent Examination or Deep Harmonization? Cooperation and Work Sharing Between Patent Offices /$$rNirmalya Syam --$$tIntellectual Property Rights (IPRs), Competition Law and Excessive Pricing of Medicines /$$rMor Bakhoum --$$tThe Impact of 'TRIPS-Plus' Rules on the Use of TRIPS Flexibilities : Dealing with the Implementation Challenges /$$rMohammed El Said --$$tPatent Linkages and Its Impact on Access to Medicines : Challenges, Opportunities for Developing Countries /$$rK.D. Raju.
001442621 506__ $$aAccess limited to authorized users.
001442621 520__ $$a"This book is an outcome of a partnership between the Max Planck Institute (MPI) for Innovation and Competition and the South Centre, which jointly organized a Global Forum on Intellectual Property, Access to Medicine and Innovation in Munich on 9-10 December 2019"--Page v
001442621 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed November 17, 2021).
001442621 650_0 $$aPatent medicines$$vCongresses.
001442621 650_0 $$aPatent medicines$$xLaw and legislation$$vCongresses.
001442621 650_6 $$aSpécialités pharmaceutiques$$vCongrès.
001442621 655_7 $$aConference papers and proceedings.$$2fast$$0(OCoLC)fst01423772
001442621 655_7 $$aConference papers and proceedings.$$2lcgft
001442621 655_7 $$aActes de congrès.$$2rvmgf
001442621 655_0 $$aElectronic books.
001442621 7001_ $$aCorrea, Carlos María,$$eeditor.
001442621 7001_ $$aHilty, Reto M.,$$d1958-$$eeditor.
001442621 7112_ $$aGlobal Forum on Innovation, Intellectual Property and Access to Medicines$$d(2019 :$$cMunich, Germany)
001442621 852__ $$bebk
001442621 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-83114-1$$zOnline Access$$91397441.1
001442621 909CO $$ooai:library.usi.edu:1442621$$pGLOBAL_SET
001442621 980__ $$aBIB
001442621 980__ $$aEBOOK
001442621 982__ $$aEbook
001442621 983__ $$aOnline
001442621 994__ $$a92$$bISE